RB loss determines selective resistance and novel vulnerabilities in ER-positive breast cancer models
Vishnu Kumarasamy, Ram Nambiar, Jianxin Wang, Hanna R. Rosenheck, Agnieszka K. Witkiewicz, Erik S. Knudsen
Topics & Concepts
Cancer researchBiologyCyclin D1Wee1Estrogen receptorXIAPTamoxifenBreast cancerCancerCell cycleCyclinInhibitor of apoptosisApoptosisProgrammed cell deathCaspaseCyclin-dependent kinase 1GeneticsAdvanced Breast Cancer TherapiesMicrotubule and mitosis dynamicsCancer-related Molecular Pathways